Tuesday, August 4, 2026

2026 Update: 39 Giant Kim Jong Un Mosaics Installed Across North Korea’s Major Cities

North Korea is replacing murals of former leaders with those of Kim Jong Un, reinforcing his cult of personality across the country.

Anthropic vs. OpenAI: Who Will Dominate the Corporate AI Market in 2026?

Anthropic partners with private equity firms to boost AI adoption and secure semiconductor infrastructure amid rising competition.

North Korea’s Kim Rolls Into China on Secretive Train Ahead of WWII Anniversary

Kim Jong Un travels to China by private train for the 80th anniversary of Victory Day, signaling strong ties with China and Russia.

Tag: BAL0891

Sillajen Presents Early BAL0891 Clinical Findings at ASCO 2026, Highlighting Safety and Early Anti-Cancer Activity

ShillaGen presented initial clinical research results of its cancer drug BAL0891 at ASCO, showcasing promising developments.

SillaJen’s Breakthrough Cancer BAL0891 Drug Set for ASCO 2026 Reveal

SillaJen's anticancer drug BAL0891 will be presented at the ASCO Annual Meeting, currently in Phase 1 trials for solid tumors and AML.

Breakthrough Cancer Drug BAL0891: Key Findings to be Revealed at AACR 2026

SillaJen's cancer drug BAL0891 will be presented at the AACR 2026 conference, highlighting its effects on gastric and breast cancer models.

Top News

- Our Sponsors Ad -

Follow us